This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Visual Impairment Treatment by Ming-Fai Fong
Introduction
Ming-Fai Fong is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of visual impairment treatment, particularly focusing on amblyopia. His innovative methods aim to address this prevalent condition that affects many children during their formative years.
Latest Patents
Ming-Fai Fong holds a patent for "Methods to treat visual impairment." Amblyopia is a common form of visual impairment that typically arises during infancy and early childhood when the visual inputs from both eyes are not well balanced. His patent discloses methods involving retinal inactivation of at least one retina to treat visual impairment in the form of amblyopia or other related conditions. This innovative approach has the potential to significantly improve the quality of life for those affected by visual impairments.
Career Highlights
Ming-Fai Fong is affiliated with the Massachusetts Institute of Technology, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing medical technologies that can help individuals with visual impairments.
Collaborations
Ming-Fai Fong has collaborated with notable colleagues, including Kevin R. Duffy and Mark Firman Bear. These partnerships have fostered an environment of innovation and creativity, leading to advancements in the treatment of visual impairments.
Conclusion
Ming-Fai Fong's contributions to the field of visual impairment treatment exemplify the impact of innovative thinking in medicine. His work not only addresses a critical health issue but also paves the way for future advancements in the treatment of amblyopia and other visual conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
